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Abstract
Chlamydia trachomatis, the causative agent of trachoma and sexually transmitted infections, employs a type III secretion
(T3S) system to deliver effector proteins into host epithelial cells to establish a replicative vacuole. Aside from the
phosphoprotein TARP, a Chlamydia effector that promotes actin re-arrangements, very few factors mediating bacterial entry
and early inclusion establishment have been characterized. Like many T3S effectors, TARP requires a chaperone (Slc1) for
efficient translocation into host cells. In this study, we defined proteins that associate with Slc1 in invasive C. trachomatis
elementary bodies (EB) by immunoprecipitation coupled with mass spectrometry. We identified Ct875, a new Slc1 client
protein and T3S effector, which we renamed TepP (Translocated early phosphoprotein). We provide evidence that T3S
effectors form large molecular weight complexes with Scl1 in vitro and that Slc1 enhances their T3S-dependent secretion in
a heterologous Yersinia T3S system. We demonstrate that TepP is translocated early during bacterial entry into epithelial
cells and is phosphorylated at tyrosine residues by host kinases. However, TepP phosphorylation occurs later than TARP,
which together with the finding that Slc1 preferentially engages TARP in EBs leads us to postulate that these effectors are
translocated into the host cell at different stages during C. trachomatis invasion. TepP co-immunoprecipitated with the
scaffolding proteins CrkI-II during infection and Crk was recruited to EBs at entry sites where it remained associated with
nascent inclusions. Importantly, C. trachomatis mutants lacking TepP failed to recruit CrkI-II to inclusions, providing genetic
confirmation of a direct role for this effector in the recruitment of a host factor. Finally, endocervical epithelial cells infected
with a tepP mutant showed altered expression of a subset of genes associated with innate immune responses. We propose
a model wherein TepP acts downstream of TARP to recruit scaffolding proteins at entry sites to initiate and amplify signaling
cascades important for the regulation of innate immune responses to Chlamydia.
Citation: Chen Y-S, Bastidas RJ, Saka HA, Carpenter VK, Richards KL, et al. (2014) The Chlamydia trachomatis Type III Secretion Chaperone Slc1 Engages Multiple
Early Effectors, Including TepP, a Tyrosine-phosphorylated Protein Required for the Recruitment of CrkI-II to Nascent Inclusions and Innate Immune Signaling. PLoS
Pathog 10(2): e1003954. doi:10.1371/journal.ppat.1003954
Editor: Joanne N. Engel, University of California San Francisco, United States of America
Received June 26, 2013; Accepted January 10, 2014; Published February 20, 2014
Copyright:  2014 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by NIH grants AI081694 and AI1000759 to RHV and AI039575 to GVP. RHV is a Burroughs Wellcome Scholar in the
Pathogenesis of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Raphael.valdivia@duke.edu
Introduction
The gram-negative bacterium Chlamydia trachomatis is the causative
agent of trachoma, the leading cause of infectious blindness
worldwide, and the major cause of bacterial sexually transmitted
infections (STI) in the developed world [1]. Approximately 2.9
million cases of visual impairment and ,1.17 million cases of
blindness are attributed to ocular infections by C. trachomatis [2]. In the
US, an estimated 2.8 million cases of Chlamydia STIs occur annually,
imposing a significant burden on the public health system [3].
Chlamydiae have a biphasic life cycle that alternates between two
unique developmental forms, the environmentally stable, infec-
tious elementary body (EB), and the replicative, but non-infectious,
reticulate body (RB) [4]. Infection starts with the attachment of
EBs to host cell membranes. After inducing its own internalization,
C. trachomatis rapidly modifies its endocytic vacuole to avoid fusion
with lysosomes [5] and migrates to a perinuclear region of the cell
[6,7] where it undergoes a developmental transition to the RB
form. Bacterial replication occurs within a membrane-bound
vacuole called an inclusion, and mid-to-late in the infectious cycle,
bacterial cell replication becomes asynchronous with RBs
transitioning back to the EB form (for reviews, see [4,8]). In late
stages of infection, the inclusion occupies the bulk of the host cell
cytoplasmic space and EBs are released to infect adjacent cells by
cell lysis or extrusion of the inclusion [9].
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Like many gram-negative bacterial pathogens, Chlamydia uses a
type III secretion (T3S) system to deliver modulators (effector
proteins) into their target host cell (reviewed in [10]). These
effectors interfere with diverse host cellular processes including
signaling, cytoskeletal rearrangements, and vesicle trafficking to
enhance bacterial entry, establish a replicative niche and evade
innate immunity [11]. The temporal manner in which effectors
are secreted is likely to be important for the proper manipulation
of host cell functions. For instance, the Translocated Actin
Recruiting Protein (TARP) is delivered into the host cytoplasm
within 5 min of bacterial attachment [12]. TARP facilitates
invasion by mediating actin re-arrangements through the direct
nucleation of F-actin polymerization and the recruitment of Rac-
specific guanine nucleotide exchange factors [13,14]. Another T3S
effector, Ct694, is delivered into host cells during Chlamydia entry
where it engages the cytoskeletal organizing protein AHNAK [15],
although the timing of Ct694 translocation in relation to TARP is
unknown. After entry, a new set of T3S effectors are synthesized
and translocated to the inclusion membrane (Inc proteins) [16]
where they mediate the recruitment of SNAREs, 14-3-3b, Rab
proteins, signaling molecules and lipid transporters [17–20].
T3S effectors share a relatively unstructured, poorly conserved
20–30 amino acid signal sequence at their N-terminus that is often
sufficient to mediate their broad secretion by T3S systems [21].
However, many effectors often require ancillary chaperone proteins
for efficient translocation into target cells. Depending on the type of
their client protein cargo, T3S chaperones can be divided into three
classes (reviewed in [22]). Class III chaperones prevent pre-
oligomerization of needle components in the bacterial cytoplasm
before secretion; class II chaperones stabilize translocators by
binding their hydrophobic regions, and class I chaperones stabilize
and/or enhance effector secretion. Depending on the number of
effectors with which they can associate, class I chaperones are
further divided into class IA and IB [23]. Class IA chaperones are
specific for single effectors and the genes encoding the chaperone-
effector pair are often co-transcribed or adjacent to each other on
the bacterial genome. Class IB chaperones associate with more than
one effector and the genes encoding these chaperones are often
unlinked from that of its cognate cargo. Many common features are
shared by class I chaperones, including small size (15,20 kDa) and
acidic isoelectric points, a stable homodimer conformation, and
ATP-independent chaperoning function [23]. Class I chaperones
contain a basic core consisting of three a-helices and five b-sheets
[24]; however, the degree of conservation at the amino acid level is
limited, making the identification of new T3S chaperones difficult.
From amino acid sequence analysis, C. trachomatis encodes at least six
putative T3S chaperones: Slc1 (Ct043), Scc1 (Ct088), Scc2 (Ct576),
Scc3 (Ct862), Ct274 and Scc4 (Ct663) [25,26]. Several studies have
validated their function as chaperones and have identified the
substrates they engaged. For instance, Slc1 from C. trachomatis
interacts with TARP and enhances its translocation/secretion in a
heterologous Yersinia T3S system [27,28]. Scc1 and Scc4 from C.
pneumoniae enhance the secretion of CopN whereas Scc3 inhibits
CopN secretion [29]. Additional T3S chaperones have been defined
functionally. For example, Mcsc (Multiple Cargo Secretion
Chaperone), which does not share any obvious sequence homology
with known chaperones, was identified based on its ability to bind
and stabilize the Inc proteins Cap1 and Ct618 [30].
A quantitative proteomic study indicated that the EB form of C.
trachomatis is equipped with a complete set of T3 secretion components
and is pre-packed with an abundant arsenal of putative T3S effectors
and chaperones [31]. In addition to TARP, Ct694 and Ct695, over
50 Chlamydia-specific hypothetical proteins lacking signal peptides
(,7% of the molar mass of the EB form) were also identified. Since
multiple effectors are likely translocated during invasion, a significant
number of these Chlamydia-specific proteins may function as effectors
with important roles early in infection. Interestingly, the EB form also
contains a full complement of T3S chaperones, with Slc1 and Mcsc
being the most abundant (Fig. 1A) [31]. Given their abundance and
that genes encoding these chaperones are genetically unlinked from
their effector protein cargos, we postulated that Slc1 and Mcsc may
engage additional effectors in EBs.
In this study, we immunoprecipited Slc1 andMcsc from Chlamydia
EB lysates and identified co-purifying proteins by mass spectrometry.
In this manner, we determined that Slc1 is in complex with multiple
T3S effectors and that co-expression of Slc1 enhanced the secretion
of these effectors in Yersinia pestis. In the process, we identified and
characterized a new effector, TepP (Translocated early phospho-
protein – Ct875), which is tyrosine-phosphorylated upon transloca-
tion into host cells. Given that the majority of TARP, but not TepP,
is pre-complexed with Slc1 within EBs, and that TepP phosphor-
ylation at Tyr residues occurs later with respect to TARP
phosphorylation, we postulate that Slc1 helps impart a hierarchy
to effector translocation during Chlamydia entry. We further show
that phosphorylated TepP associates with host scaffolding proteins
Crk-I and Crk-II and that the recruitment of Crk proteins to nascent
inclusions is absent in cells infected with a Chlamydia mutant
harboring a tepP null allele and is restored in complemented strain. In
addition, endocervical epithelial cells infected with this mutant
exhibited transcriptional changes in a subset of innate immunity-
related genes. We propose a model wherein TepP acts downstream
of TARP to recruit scaffolding proteins that initiate and amplify
signaling cascades important for establishing a replicative niche for
Chlamydia within the infected host.
Results
The type III secretion chaperone Slc1 associates with
multiple C. trachomatis proteins
A quantitative proteomics analysis of C. trachomatis indicated that
around 2% of the EB total mass is composed of T3S chaperones,
Author Summary
Chlamydia trachomatis is an obligate intracellular bacterial
pathogen that causes a range of human diseases of
significant public health importance. To create a suitable
replicative niche within its host, Chlamydia delivers
effector proteins across mammalian membranes via a
syringe-like apparatus termed a Type III secretion (T3S)
system. The lack of a robust system for the molecular
genetic manipulation of these pathogens has hindered
progress in identifying and characterizing T3S effectors. In
this study, we took a mass spectrometry-based approach
to identify Chlamydia effector proteins based on their
interaction with Slc1, an abundant T3S chaperone. We
identified a previously uncharacterized protein, Ct875/
TepP, as a new T3S effector and determined that TepP is
phosphorylated upon translocation into host cells, leading
to the recruitment of the host scaffolding protein Crk and
presumably manipulating Crk-dependent signaling func-
tions. Finally, we provide genetic confirmation of the role
of TepP in recruiting Crk and in modulating the expression
of genes involved in innate immune responses to
Chlamydia. This study is the first example of genetic
validation of the function of a T3S effector in Chlamydia
and a new example of a bacterial effector that directly co-
opts the oncoprotein Crk to modulate host cell signaling
events.
Chlamydia TepP Recruits Crk to Pathogenic Vacuoles
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with Slc1, Mcsc and Scc2 accounting for over 99% of all known
T3S chaperones (Fig. 1A) [31]. Slc1 forms complexes with TARP
and enhances TARP translocation into HeLa cells when both
proteins are co-expressed in Yersinia enterocolitica [27,28]. In EBs,
the majority of TARP is in complex with Slc1, and both TARP
and Slc1 are present at similar molar concentrations [31].
However, since slc1 is located ,500 kb from tarP, it is unlikely
that Slc1 constitutes a TARP-specific Class IA T3S chaperone.
Furthermore, because putative T3S effectors in EBs are present at
a 10 fold molar excess over the three major T3S chaperones [31],
we hypothesized that chaperones like Slc1 and Mcsc must bind
multiple effectors. We further hypothesized that these chaperones
bind their cargos in a hierarchical manner and thus impart
coherence to effector secretion. To test this premise we determined
the compendium of EB proteins that associate with Slc1 and Mcsc.
We immunoprecipitated (IP) Slc1 and Mcsc under native
conditions from EB lysates and identified all proteins that
associated with each individual chaperone by LC-MS/MS (liquid
chromatography-tandem mass spectrometry). As previously re-
ported [27,31] TARP was one of the major proteins that co-
purified with Slc1. In addition, two predicted T3S effectors, Ct694
and Ct695, and two hypothetical proteins, Ct365 and Ct875 co-
purified with Slc1 (Fig. 1B). As described in the sections below, we
renamed Ct875 as TepP to reflect the new functions defined in this
study for this protein. CdsD, a T3S apparatus component, and
proteins involved in metabolism were also specifically detected in
the Slc1 IP samples (Table S1). Interestingly, both Mcsc and Slc1
mutually co-IP each other. Since these chaperones are not
predicted to form heterodimers [27], this result suggests that
Slc1 and Mcsc homodimers may co-chaperone the same cargo,
presumably Ct365, which was detected in both IP samples. We
validated the LC-MS/MS results by immunoblot analysis of the IP
materials and immunodepleted flow-through samples with anti-
bodies specific to Slc1 and the identified co-precipitating proteins
(Fig. 1C). We detected TARP, Ct694, Mcsc, CdsD and Ct875/
TepP in samples immunoprecipitated with anti-Slc1 antisera but
not with pre-immune antisera. In contrast, MOMP, a very
abundant EB protein, was not detected in the Slc1 IP samples,
highlighting the specificity of the immunoisolations. As we had
previously observed, immunodepletion of Slc1 from EB lysates led
to a co-depletion of TARP [31]. Similarly, Ct694 was also
substantially depleted, indicating that these two effectors within
EBs are largely present in Sc1-containing complexes. The other
co-purifying targets were not efficiently co-depleted which suggest
that the complexes were either unstable or present in sub-
stoichiometric amounts.
Slc1 forms stable complexes with the effectors TARP,
Ct694, Ct695 and Ct875/TepP
We next tested if the major interactions identified for Slc1,
especially those with potential T3S effectors, could be recapitu-
lated in vitro with recombinant proteins. The most abundant
proteins that associated with Slc1 are Ct875/TepP, TARP, Ct694,
Ct695 and Ct365. We expressed these proteins as GST-tagged
fusion proteins together with untagged Slc1 in E. coli and tested
whether Slc1 would co-purify on glutathione sepharose beads.
Figure 1. A distinct set of Chlamydia proteins associate with Slc1 in the Elementary Body (EB) form. A) Relative protein mass composition
of the C. trachomatis EB. Approximately 2% of total EB protein mass is comprised of T3S chaperones, with Slc1, Scc2 and Mcsc accounting for over
99% of their mass. This figure represents a reanalysis of data reported in [31]. B) Protein interaction network for Slc1 and Mcsc. Cell lysates from
gradient purified EBs were incubated with anti-Slc1 antibodies, anti-Mcsc antibodies, or non-specific IgG cross-linked to an agarose resin. Bound
proteins were eluted at low pH, digested with trypsin and identified by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS)
(Table S1). Only proteins that displayed specific interactions are shown. C) Specificity of Slc1-interactions. EB lysates were incubated with either anti-
Slc1 antisera or pre-immune sera, and bound proteins were captured on Protein A/G agarose resin. The eluate (bound) and flow through (unbound)
from both Slc1 IP and control IP were analyzed by immunoblotting with antibodies against selected proteins. MOMP is an abundant Chlamydia
protein that serves as control for the specificity of the interactions shown.
doi:10.1371/journal.ppat.1003954.g001
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Because, we could not express the predicted inclusion membrane
protein Ct365 [32] in E. coli, this potential effector was not studied
further (data not shown). Pull downs of GST-tagged TARP,
Ct694, Ct695 and Ct875/TepP with glutathione beads led to the
co-isolation of Slc1. This binding was specific as neither GST nor
GST-tagged Ct288, another inclusion membrane protein [33] that
is present in EBs, led to Slc1 co-purification (Fig. 2A). T3S
chaperones form stable complexes with a predicted 2:1 stoichi-
ometry of chaperone to effector protein [34]. To test if such larger
complexes could form, we co-expressed in E. coli untagged Slc1
and hexahistidine-tagged full length TARP, Ct694, Ct695, or
Ct875/TepP and isolated protein complexes on nickel resins. The
bound material was eluted from the resin with imidazole and
analyzed by gel filtration chromatography. All four proteins
formed stable complexes with Slc1, with apparent molecular
weights above 150 kDa, which are larger than that expected for
2:1 chaperone effector complexes (Fig. 2B). Although gel filtration
cannot always accurately predict molecular sizes for non-globular
proteins [35], given that TARP forms hexamers and that the
oligomerization domain is distinct from the Slc1 binding domain
[14,27], we postulate that size discrepancies between Slc1/TARP
and the other Slc1/effector complexes represent the formation of
higher order oligomeric forms.
Slc1 enhances the secretion of Ct694, Ct695 and Ct875/
TepP in a heterologous T3S system
Based on the gel filtration results we speculated that Slc1, as
reported for TARP [27], would act as T3S chaperone and
enhance the secretion of Ct694, Ct695, and Ct875/TepP. To test
this premise, we reconstituted chaperone-assisted T3S in Y. pestis as
previously described [29]. Effectors were expressed in Y. pestis as
either untagged (Ct694 and Ct875) or FLAG-tagged (Ct695)
proteins under the control of an arabinose-inducible promoter in
the presence of Slc1 or Mcsc. Upon induction of T3S by calcium
chelation, Ct694 and Ct695 were secreted into the supernatants as
previously reported [15]. The secretion of Ct694 and Ct695 was
enhanced two to three fold when Slc1, but not Mcsc, was co-
expressed, suggesting that Slc1 functions as a bona fide T3S
chaperone specific for these proteins (Fig. 2C). Consistent with the
known behavior of most T3S chaperones, neither Slc1 nor Mcsc
were secreted into supernatants (data not shown). The role of Slc1
in TARP secretion in this system could not be determined as
expression of full length TARP in the presence of Slc1 hindered Y.
pestis T3S (data not shown). Full length Ct875/TepP was also a
target of secretion by the Y. pestis T3S system, even though Ct875/
TepP is not predicted to have a T3S signal [21,31,36], and its
secretion was enhanced by Slc1.
Ct875/TepP is the most abundant Chlamydia-specific hypothet-
ical protein pre-packed in EBs [31]. We speculated that this
protein is secreted early during EB attachment to cells and that it
plays a role in invasion and/or establishment of the nascent
inclusion. Consistent with this, an analysis of Ct875/TepP
localization by immunofluorescence microscopy indicated a close
association of Ct875/TepP with EBs by 2 hours post infection
(hpi) in HeLa cells (Fig. 3A). However, the localization of Ct875/
TepP was distinct from that of chlamydial LPS, suggesting
translocation of Ct875/TepP from the EB at attachment sites
(Fig. 3A). This localization pattern is similar to what has been
described for TARP and Ct694 [15], and is clearly distinct from
that of Slc1 which is mostly localized to the bacterial cytosol.
Overall, these findings provide experimental evidence that Ct875/
TepP is a new T3S effector translocated early during EB entry into
epithelial cells.
TepP (Ct875) is phosphorylated upon infection with
kinetics distinct from TARP
Approximately 5–6 distinct proteins are tyrosine-phosphorylat-
ed early upon infection with C. trachomatis [37,38]. Most of these
proteins were originally assumed to be host proteins that were
phosphorylated as a consequence of the activation of multiple
kinase signaling pathways by Chlamydia, until TARP was identified
as one of these major tyrosine-phosphorylated proteins [12].
Because Ct875/TepP has a molecular weight of 65 kDa, similar to
one of the major tyrosine-phosphorylated protein detected within
15 minutes of C. trachomatis LGV-L2 infection [37] (Fig. 3B), we
considered the possibility that Ct875/TepP is also tyrosine-
phosphorylated. Consistent with this, analysis by indirect immu-
nofluorescence microscopy indicated that anti-Ct875/TepP and
anti-phosphotyrosine signals co-localized around bacteria at 2 hpi
(Fig. 3C). Next, we determined that Ct875/TepP immunoprecip-
itated from infected HeLa cell lysates, but not from EBs lysates,
was detected by anti-phosphotyrosine antibodies in immunoblots,
suggesting that Ct875/TepP is tyrosine-phosphorylated upon
association with host cells (Fig. 3D). Phosphorylation of TepP
provided us an opportunity to monitor the kinetics of its
translocation into cells. EB infections were synchronized at 4uC
and shifted to 37uC for various time intervals within a 1 h span.
Infected samples were lysed, split in two and TARP and TepP
were immunoprecipitated. Total TARP, TepP and tyrosine-
phosphorylated protein in the IP material was monitored with
specific antibodies. We observed that tyrosine phosphorylation of
TepP was delayed with respect to TARP by ,10 min (Fig. 3E),
suggesting either that kinases responsible for TepP phosphoryla-
tion are recruited with delayed kinetics to EB entry sites or that
TARP translocation from EBs precedes TepP. However, TepP
might not be the major ,65–70 kDa phosphoprotein since the
TepP band only partly overlapped with the major ,65–70 kDa
phosphotyrosine protein bands in dual labeling immunoblots
(Fig. 3F).
We proceeded to map the phosphorylation sites on translocated
Ct875/TepP by mass spectrometry. Infections were scaled up and
Ct875/TepP was IP at 4 hpi in the presence of phosphatase
inhibitors and processed for phospho-proteomics analysis. Four
phospho-peptides were detected in the sample: two contained
phosphorylated tyrosine (Y43 and Y496) and two phosphorylated
serine residues (S410 and S415) (Fig. S1, Fig. 4A). Because the
peptide spanning Y496 is part of a tandem repeat (ASDYDLPR), it is
unclear if one or both tyrosine residues (Y496 and Y504) are
phosphorylated. Overall, these results indicate that Ct875/TepP is
phosphorylated at multiple residues during infection and thus we
renamed this protein as TepP for translocated early phosphoprotein.
Crk, an adaptor protein, associates with TepP and is
recruited to nascent inclusions
Protein tyrosine phosphorylation plays an important role in
signal transduction by mediating the recruitment of proteins
containing Src homology 2 (SH2) and/or phosphotyrosine binding
(PTB) domains to target proteins [39]. Analysis of the TepP
phosphopeptides using NetPhorest (http://netphorest.info/) [40]
indicated the presence of a consensus pYxxP binding site
(ASDYDLPR) for the scaffolding protein Crk [41]. Crk is an
adaptor protein that mediates phosphorylation-mediated regula-
tion of cytoskeletal dynamics, cell adhesion and migration,
phagocytosis and tumorogenesis [42]. Mammals express Crk-I
and Crk-II, two alternatively spliced forms of CRK, and the Crk-
like protein, Crk-L. Crk proteins contain SH2 and SH3 domains,
which mediate binding to phosphorylated tyrosine residues and
Chlamydia TepP Recruits Crk to Pathogenic Vacuoles
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proline-rich domains, respectively [42]. To test if TepP translo-
cated from EBs associated with Crk proteins, we performed a time
course of infection and immunoprecipitated TepP in the presence
of phosphatase inhibitors. Chlamydia infection did not alter the
steady state levels of CrkI-II (Fig. S2); whereas increasing amounts
of CrkI and CrkII co-IP with TepP as the infection progressed
(Fig. 4B), indicating that these proteins are part of a complex. By
immunofluorescence microscopy, we further observed endogenous
Crk recruited to bacteria as early as 1 hpi and that this association
continued past 8 hours, a point at which nascent inclusions have
migrated to the microtubule organizing center (Fig. 4C). To test if
the association of TepP with Crk is direct, we next examined if
recombinant TepP could bind to Crk in vitro. We found that the
binding between TepP and GST-Crk was significantly enhanced
by in vitro phosphorylation of TepP and reduced after phosphatase
treatment (Fig. S3, Text S1), suggesting that TepP phosphoryla-
tion is important for the recruitment of Crk. Together, these data
are consistent with a model wherein TepP, after being secreted
into host cells, is tyrosine-phosphorylated and recruits Crk to
nascent inclusions, presumably through interactions with its SH2
domain.
TepP is required for the recruitment of Crk to nascent
inclusions
Although Chlamydia spp. lacks a system for performing targeted
gene disruptions, chemically-derived mutants can be readily
generated and loss-of-function mutations can be identified by whole
genome sequencing [43]. Using such an approach, our group has
recently generated and sequenced a comprehensive collection of
ethyl methyl sulfonate (EMS)-derived mutants of C. trachomatis LGV-
L2 (unpublished results). We identified 6 strains with mutations in
TepP, including strain CTL2-M062, bearing a G to A transversion
that led to a premature stop codon at amino acid 103 (W103*)
(Fig. 5A). By immunoblot analysis, EBs from CTL2-M062 lacked
any detectable TepP, suggesting that the truncated form of TepP
was either unstable or not properly expressed (Fig. 5B). Interest-
ingly, even though TepP is not the predominant ,65–70 kDa
tyrosine-phosphorylated protein observed early during C. trachomatis
Figure 2. Slc1 associates as stable, multi-protein complexes with TARP, Ct694, Ct695 and Ct875/TepP, and enhances their secretion
via the T3S system. A–B) Slc1 binds its putative target effectors in vitro. Slc1 was co-expressed in E. coli with GST-tagged TARP, Ct694, Ct695 and
Ct875/TepP fusion proteins. The GST-tagged proteins were isolated from cell lysates with glutathione sepharose beads, and the relative levels of Slc1
co-isolated was assessed by immunoblot analysis (A). GST and GST-288 served as negative controls. To assess the relative size of these complexes,
TARP, Ct694, Ct695 and Ct875/TepP were fused to a hexahistidine tag and co-expressed with Slc1. Bound proteins were purified using a Nickel resin,
eluted with 500 mM Imidazole, and analyzed by gel filtration chromatography (B). Fraction numbers are provided on the top. Molecular size markers:
Alcohol Dehydrogenase (150 kDa), Conalbumin (75 kDa) and Carbonic Anhydrase (29 kDa), peaked at F16-17, F20-21 and F26, respectively. No peak
was observed between fractions 8–20 in Slc1-6xHis sample in the absence of co-expressed effectors. C) Slc1 enhances the T3S-dependent secretion
of Ct694, Ct695 and Ct875/TepP. Y. pestis KIM8-E (Dail) was co-transformed with plasmids expressing Ct694, Ct875/TepP and FLAG-tagged Ct695 and
untagged Slc1 or Mcsc in the combinations shown. T3S was induced by calcium chelation and the relative amount of protein secreted into the
supernatants was assessed by quantitative immunoblots. Sup-cell free supernatant. Mcsc did not enhance the secretion of effectors, indicating that
the secretion chaperone activity of Slc1 is specific for its target substrates.
doi:10.1371/journal.ppat.1003954.g002
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infection, these phosphorylated species were no longer detected
when cells were infected with the TepP-deficient CTL2-M062
mutant (Fig. 5C); whereas the levels of the phospho-TARP band
(,150 kDa) were unaltered. These results indicate that TepP may
induce the phosphorylation of additional host and or secreted
bacterial proteins at the early stages of infection. Next, we
determined whether Crk association with nascent inclusions was
dependent on TepP. HeLa cells were infected with either wild type
or the TepP-deficient C. trachomatismutant and the co-localization of
bacteria with Crk was assessed by immunofluorescence microscopy.
Crk was no longer associated with intracellular CTL2-M062 by
8 hpi (Fig. 5D).
The original TepP deficient isolate carried an additional 11
EMS-induced single nucleotide variants (SNVs) (Fig. 5A; Table
S3). To exclude the possibility that these SNVs contributed to the
lack of Crk recruitment to nascent inclusions, we generated
recombinant strains between the TepP deficient isolate (generated
in a RifR background) and a spectinomycin (SpcR) LGV-L2 strain
by co-infection of cells as previously described [43]. Double drug
resistant recombinants were plaque purified and screened by
allele-specific PCR to determine the relative segregation of
mutations present in the original TepP-deficient isolate. A total
of 200 recombinants were screened and four co-isogenic strains
were identified where various assortment of mutations were
present (Fig. S5). The marked reduction of the ,65–70 kDa signal
in phosphotyrosine immunoblots was only observed in the strain
lacking TepP (Fig. 5E). Similarly, Crk recruitment to nascent
inclusions was only impaired in strains encoding the TepPW103*
variant (Fig. 5F), providing further genetic support to the notion
that TepP is directly responsible for the recruitment of Crk to
inclusions.
Finally, to provide final genetic confirmation of the role of TepP
in mediating these events, we took advantage of recent develop-
ments in DNA transformation in C. trachomatis [44]. We
transformed the recombinant TepPW103* strain with a C.
trachomatis-E. coli shuttle plasmid expressing the tepP gene under
the control of its endogenous promoter or the empty vector control
and selected for stable transformants in the presence of penicillin.
The transformed strains expressed TepP to a similar level as wild
type strains (Fig. 6A). An immunoblot analysis of infected cells
showed the restoration of the ,65–70 kDa phosphotyrosine
immunosignals in TepP complemented strains but not in strains
transformed with the empty vector (Fig. 6B). In addition, Crk
recruitment to nascent Chlamydia inclusions was restored (Fig. 6C).
Both results, the restoration of protein phosphorylation and Crk
recruitment to nascent inclusions, were observed when infecting
Figure 3. TepP/Ct875 is secreted at Chlamydia entry sites and is phosphorylated upon translocation. A) TepP is secreted from EBs early
during infection. HeLa cells were infected with LGV-L2 at a MOI of 20 for 2 hr. Cells were fixed, permeabilized and immunostained with antibodies
against Chlamydia LPS (red), Ct875/TepP (green) and Slc1 (green). Scale bar: 1 mm. B) Immunoblot analysis of total cell lysates of Chlamydia infected
cells shows the appearance of at least three major tyrosine-phosphorylated proteins (.150 kDa, 100 kDa, and 65–70 kDa) within 1 hpi. C) TepP
colocalizes with anti-phospho-Tyr signals at Chlamydia entry sites. HeLa cells were infected as in A) and immunostained with anti-TepP (green) and
anti-p-Tyr (red) antibodies. Host and bacterial DNA were stained with DAPI (blue). Scale bar: 10 mm (upper panel); 2 mm (lower panel). D) TepP is
phosphorylated at tyrosine residues upon EB association with host cells. Cells were infected as in B) with an MOI of 100 for the indicated times and
TepP was immunoprecipitated from cell lysates and analyzed by immunoblotting with anti-TepP and anti p-Tyr antibodies. TepP was recognized by
anti p-Tyr antibodies only upon association with host cells. E–F) TARP and TepP are tyrosine-phosphorylated at different rates during Chlamydia
infection. HeLa cells were infected as in B) and total protein lysates were generated at 0, 5, 15, 30 min and 1 hpi and TepP and TARP was IP as above
with anti-TARP or anti-TepP antibodies followed by immunoblot analysis with anti-TARP, -TepP and p-Tyr antibodies (E). Note relative delay in TepP
tyrosine phosphorylation with respect to TARP. The prominent higher molecular weight tyrosine-phosphorylated band corresponds to TARP, as
assessed by 2-color immunofluorescence-detection. In contrast, TepP only partially overlaps with the major 65–70 kDa tyrosine-phosphorylated
proteins (F). MOMP: major outer membrane protein, Uninf: uninfected.
doi:10.1371/journal.ppat.1003954.g003
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A2EN cells, a newly derived endocervical epithelial cell line [45]
(data not shown). Taken together, our results confirm that TepP is
the major contributor, either directly or indirectly, to the tyrosine-
phosphorylation of multiple proteins early during C. trachomatis
infection and the subsequent recruitment of Crk to nascent
inclusions.
TepP regulates the expression of genes associated with
innate immune responses
Although the CTL2-M062 had a ,15 fold growth defect
compared to the wild type parental strain, we could not
unambiguously link this growth defect to strains bearing the tepP
mutant allele (data not shown). To address whether TepP played a
role in promoting C. trachomatis replication or infectivity, we
compared the ability of the tepP mutants transformed with the tepP
expressing plasmid or plasmid alone to generate infectious
progeny. We observed no differences in the generation of EBs
among these strains in either HeLa cells (Fig. S6D and Text S1) or
in A2EN cells (data not shown). Similarly, silencing of Crk, a
major TepP-binding partner, with siRNAs in HeLa cells did not
impact C. trachomatis replication (Fig. S6A–C and Text S1).
These observations suggest that TepP is not essential for C.
trachomatis replication in cell culture models of infection, although
we cannot rule out a role for TepP in promoting invasion or
intracellular survival in other cell types or in the context of intact
tissues and an active immune system. However, given the
observation that TepP recruits Crk, a scaffolding protein
important in cell signaling, we hypothesized that the presence of
TepP should lead to defined transcriptional responses by the
infected cell. We compared the global transcriptional profile of
mock infected A2EN cells or A2EN cells infected with the tepP
mutant and its complemented counterpart for 4 h. A microarray
analysis revealed 33 genes displaying greater than 1.5 fold changes
in gene expression levels (Fig. 7A and Table S4). A Gene Ontology
(GO) analysis of these differentially expressed genes revealed an
enrichment for genes with immunity-related functions (data not
shown). We next validated by quantitative-PCR, the expression of
five of these genes: IL-6 and CXCL3, and MAP3k8, IFIT1 and
IFIT2, whose transcription decrease and increase, respectively,
depending on the presence of TepP (Fig. 7B). Interestingly, the
fold-change for IFIT1 and IFIT2 changed from 2 fold to more
than 10 fold by 8 hpi; whereas the level of fold-change for
MAP3k8 did not (Fig. 7C). These data suggests that one of the
functions of TepP is to modulate gene expression in the early
stages of infection, presumably to impact the type and magnitude
of the ensuing innate immune response.
Discussion
Approximately 5–10% of the C. trachomatis genome encodes for
proteins with putative T3S signals [21,36]. These potential effector
proteins are presumably translocated into host epithelial cells at
various stages of infection to mediate epithelial cell invasion,
Figure 4. Crk-I and Crk-II bind to tyrosine-phosphorylated TepP and are recruited to nascent inclusions early during infection. A)
Cartoon schematic of TepP phosphorylation sites identified by mass spectrometry (Fig. S1). B) CrkI and CrkII co-IP with TepP. HeLa cells were infected
with L2 at MOI of 100 for 1, 2, 4, 6 and 8 hours. Cell lysates were immunoprecipitated with anti-TepP antibodies and the bound proteins were
analyzed by immunoblot with anti-Crk, TepP and p-Tyr antibodies. Both isoforms of Crk, CrkI (lower band) and CrkII (upper band), co-IP with TepP.
Uninf-uninfected. C) CrkI-II is recruited to Chlamydia entry sites and nascent inclusions. HeLa cells were infected with L2 at an MOI of 20 for 1 and
8 hours. Cells were fixed and stained with anti-MOMP (green) and anti-Crk (red) antibodies. Left panels are magnified images from boxed areas.
Examples of sites of association between bacteria and Crk are marked by arrows. DAPI was used to stain nucleic acids. CrkI-II was recruited to
Chlamydia entry sites by 1 hpi and this association continued after the nascent inclusions had trafficked to the host cells’ perinuclear region.
doi:10.1371/journal.ppat.1003954.g004
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establishment of a protected replicative vacuole, and evasion of
innate immune responses (reviewed in [11]). Because Chlamydia
cannot be readily manipulated with molecular genetic tools, most
approaches to identify effectors have been indirect and relied on
heterologous expression systems [46]. To date, only two effectors
that are secreted in the early stage of infection, TARP and Ct694,
have been experimentally validated in C. trachomatis [12,15]. Given
the complexity of interactions with the host cell during Chlamydia
entry and nascent inclusion development, we expected additional
effectors to be secreted upon the association of the EB with its
target epithelial cell and that most of these effectors are pre-loaded
in EBs. Indeed, a quantitative analysis of the C. trachomatis EB
proteome [31] suggested the presence of at least 20 abundant
hypothetical proteins with putative T3S signals. EBs are also pre-
loaded with most of the predicted T3S chaperones encoded by the
Chlamydia genome. However, putative T3S effectors are in molar
excess to that of available T3S chaperones, which led us to
speculate that these chaperones may engage multiple effectors.
The two most abundant T3S chaperones in EBs are the TARP
chaperone Slc1 [27,31] and Mcsc, which engages at least two
inclusion membrane proteins during the RB stage [30]. Because the
genes encoding Slc1 and Mcsc are unlinked from that of their
effectors, we considered the possibility that these chaperones engage
multiple effectors in EBs. To test this premise we decided to identify
the set of proteins that stably associate with Slc1 andMcsc at the EB
stage by IP coupled to mass spectrometry. We only found a limited
Figure 5. TepP is required for the recruitment of Crk to nascent inclusions. A) Physical map of single nucleotide variants identified in strain
CTL2-M062, a chemically derived LGV-L2 mutant containing a nonsense mutation in the codon for amino acid 103 of TepP. Non synonymous
mutations were identified by whole genome sequencing and verified by Sanger sequencing. Key differences from the parental reference strain are
highlighted. B–C) TepP is required for the accumulation of major tyrosine-phosphorylated proteins in Chlamydia infected cells. Immunoblot analysis
of the EB lysate of CTL2-M062 shows no detectable levels of TepP compared to wild type LGV-L2 (WT) (B). HeLa cells were infected with wild type
LGV-L2 (WT) or CTL2-M062 at an MOI of 50 and samples were collected at indicated time points and analyzed by immunoblot with antibodies against
p-Tyr and MOMP. Arrows indicate major TepP-dependent tyrosine-phosphorylated proteins (C). D) Crk does not associate with nascent inclusions in
CTL2-M062 infected cells. Immunofluorescence staining of HeLa cells infected with wild type LGV-L2 and CTL2-M062 for 8 h. Cells were stained with
anti-Crk (red) and anti-MOMP (green) antibodies, and with DAPI (blue). Crk recruitment was absent in a TepP deficient strain. Scale bar: 20 mm. E–F)
The tepP mutation is genetically linked to the lack of the infection-induced p65-70 kDa tyrosine-phosphorylated proteins and the loss of Crk
recruitment to nascent inclusions. Various recombinant strains generated from a cross between CTL2-M062 and wild type LGV-L2 were tested for
TepP expression (Fig. S4, S5) and tested for the presence of the p65-70 kDa p-Tyr proteins (E) and recruitment of Crk to nascent inclusions (F).
doi:10.1371/journal.ppat.1003954.g005
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number of interactions forMcsc in EBs. In contrast, Slc1 engaged at
least four new substrates of the T3S system: Ct365, Ct694, Ct695
and Ct875/TepP, a protein not previously thought to harbor a T3S
signal based on early prediction algorithms [21,36]. Consistent with
our findings, Mota’s group recently showed that Slc1 can interact
with Ct694 and Ct695 in vitro and enhances their secretion in Y.
enterocolitica [28].
In addition to their traditional role in escorting cargo for
secretion, T3S chaperones can regulate additional cellular
functions. For instance, SicA, a Salmonella T3S chaperone for the
effector SipA, directly interacts with the transcriptional activator
InvF, and this complex activates the expression of T3S genes [47].
Similarly, SycD (LcrH), the chaperone for the translocator protein
YopD, functions with YopD to represses Yop synthesis in Yersinia
pseudotuberculosis [48]. In Chlamydia, the chaperone Scc4 (Ct663)
negatively regulates s66–dependent transcription by directly
interacting with both s66 and b subunits of RNA polymerase
[49]. At least one T3S chaperone, the Shigella Spa15 protein, is
secreted and plays a role in preventing apoptosis of the infected
host cell [50]. Slc1 is unlikely to be a T3S cargo as it was not
secreted by Yersinia (data not shown) and Slc1 localization was
restricted to EBs early in infection (Fig. 3A). Nevertheless, we
identified several additional proteins that specifically co-IP with
Slc1, including the late transcription unit B protein (ltuB, Ct080), a
serine protease (HtrA), a putative aminopeptidase (PepA) and a
transaldolase (TalB). While not experimentally confirmed, it is
unlikely that any of these proteins constitute T3S effectors as
computational programs aimed at identifying T3S signals give
these proteins very low confidence for T3S (www.effectors.org). At
present, it is unclear whether these interactions are direct.
However, one could envision scenarios wherein Slc1 could
interact with non-effector proteins to signal the successful entry
into a host cell after it is no longer physical bound to an effector.
Such a mechanism might be especially important for an
intracellular pathogen like Chlamydia, where physical engagement
of the T3S apparatus may need to be coupled to rapid metabolic
adaptations and post-translational modifications that drive suc-
cessful colonization of the target cell.
T3S chaperones enhance the secretion of its bound cargo by
stabilizing effectors in the bacterial cytoplasm and maintaining
Figure 6. Genetic complementation of a Chlamydia tepP mutant restores the normal tyrosine-phosphorylation pattern of multiple
proteins and rescues Crk recruitment to nascent inclusions. A) The recombinant TepPW103* strain CTL2-M062G1 was transformed with an
empty vector (Vec.) or a vector harboring the wild type tepP gene (pTepP). Immunoblot analysis of EBs derived from these strains with anti-TepP
antibodies confirms the complementation of TepP expression to wild type levels (LGV-L2). Slc1 and RpoB/B’ levels are shown as loading controls. B)
The complemented recombinant TepPW103* strain restored the pattern of tyrosine-phosphorylation induced during Chlamydia infection. Confluent
HeLa cells were infected with CTL2-M062G1 strains described in (A) at an MOI of 50 and total protein lysates were collected at indicated time points.
Samples were subjected to immunoblot analysis with antibodies against p-Tyr and MOMP. Arrows indicate phosphotyrosine bands restored after
TepP complementation. C) The complemented recombinant TepPW103* strains rescued Crk recruitment to nascent Chlamydia inclusions. Cells were
infected for 8 hours with CTL2-M062G1 strains described in (A) at an MOI of 20, and immunostained with anti-Crk (red) and anti-MOMP (green)
antibodies, and DAPI (blue).
doi:10.1371/journal.ppat.1003954.g006
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them in a secretion competent state [51]. In addition, T3S
chaperones can also prioritize the secretion of effectors. For
instance, YopE, a Yersinia T3S effector, lacking a SycE chaperone
binding site, is secreted in the absence of other T3S effectors.
However, YopE secretion is severely impaired when other
effectors are allowed to compete with it, indicating that additional
secretion signals are either unmasked or conferred by the T3S
chaperone [52]. Similarly, CesT from enteropathogenic Escherichia
coli (EPEC), binds to 9,10 T3S effectors but one of the cargos,
Tir, is secreted first and Tir secretion is important for secretion of
the remaining effectors [53]. Indeed, a real-time analysis of CesT-
dependent traslocation revealed a distinct order in the transloca-
tion of EPEC effectors and the effector-chaperone interaction is
suggested to be one of the factors influencing translocation
efficiency [54]. Based on these findings, we hypothesized that T3S
chaperones would play a prominent role in establishing a
hierarchy to the secretion of effectors by Chlamydia EBs. The most
abundant T3S chaperone in EBs is Slc1, which, like CesT,
engages multiple effectors. TARP, one of Slc1’s cargos [27], is
secreted within 5 min upon EB attachment to epithelial cells [12].
Interestingly, the majority of TARP in EBs is found pre-
complexed with Slc1 (Fig. 1C) [31], implying that this pre-
engagement with its chaperone could prime TARP for rapid
secretion. Similarly, a significant proportion of Ct694 within EBs is
pre-complexed with Slc1 (Fig. 1C), suggesting that Ct694 may be
also secreted very early during infection, possibly at the same time
as TARP. In contrast, only a minor portion of TepP was present in
complexes with Slc1 in EBs, even though TepP is more abundant
than TARP and Ct694 [31]. Given these observations, we
considered a model wherein T3S substrates pre-bound by Slc1
in EBs, such as TARP and Ct694, will be delivered first, followed
by TepP and potentially other effectors which do not exist as pre-
formed effector-chaperone complexes in EBs. Consistent with this
model, TepP was tyrosine-phosphorylated later than TARP
(Fig. 3E). Although we cannot exclude the possibility that TepP-
specific tyrosine kinases are recruited later than those that
phosphorylate TARP, our preliminary results indicate that TepP
is phosphorylated by kinases that also target TARP (data not
Figure 7. Global transcriptional profiling links TepP function to immune-related responses. A) Microarray analysis identified 33 host
genes that have .1.5 fold-change in transcription between recombinant TepPW103* strains (CTL2-M062G1) transformed with empty vector (Vec) and
vector containing wild type tepP gene (pTepP). A2EN epithelial cells were infected for 4 hours. Results shown were from duplicate biological samples.
B) Q-PCR results validated transcriptional change observed for 5 immune-related genes at 4 hpi. Fold-change in mRNA abundance was normalized to
CTL2-M062G1 (Vec). C) TepP-dependent elevation of IFIT genes expression at 8 hpi. Q-PCR results of MAP3k8, IFIT1 and IFIT2 mRNA in A2EN cells
infected as in (A). All data shown were as means 6 standard deviations from three independent biological replicates. *, P,0.05; **, P,0.01; ***,
P,0.001 (one-way analysis of variance and Tukey’s multiple-comparison test).
doi:10.1371/journal.ppat.1003954.g007
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shown), making this possibility less likely. Overall, the delayed
phosphorylation of TepP, coupled with the relative abundance of
Slc1-TARP as compared to Slc1-TepP complexes within EBs lead
us to propose that Slc1 imparts a hierarchy to the translocation of
effectors during Chlamydia invasion (Fig. 8).
Our findings indicate that TepP is a novel C. trachomatis effector
that is targeted for tyrosine phosphorylation upon delivery into
epithelial cells. This protein is highly conserved in all serovars of C.
trachomatis, including ocular, genital and LGV strains. It shares
49% identity with TC_0268, ortholog in C. muridarum and less than
25% identity with potential orthologs in other Chlamydiae spp
(http://www.uniprot.org/blast). TepP is phosphorylated at both
tyrosine and serine residues (Fig. 4A), with a phosphotyrosine
residue mapping to the peptide ASDYDLPR, which is repeated in
tandem between amino acids 496–504. This phosphorylation site
matches the pYxxP consensus binding site for the host adaptor
proteins Crk-I and Crk-II [41]. Indeed, we found that both Crk
proteins co-IP with endogenous TepP during the early stages of
Chlamydia infection (Fig. 4B). This interaction is likely to be direct
and dependent on tyrosine phosphorylation since recombinant
TepP only interacts with GST-CrK upon in vitro phosphorylation
(Fig. S3). Consistent with these observations, CrkI-II associated
with EBs at entry sites and nascent inclusions (Fig. 4C).
Importantly, the lack of CrkI-II association with nascent inclusions
in a tepP null mutant strain and restoration after complementation
provided genetic confirmation that TepP is required for Crk
recruitment.
CrkI-II are well-characterized scaffolding proteins that organize
cytoskeletal rearrangement and signal transduction events [42].
The SH2 domain of Crk interacts with tyrosine-phosphorylated
proteins. The SH3 domain, in turn, can interact with multiple
proteins including guanine nucleotide exchange factors (GEFs)
such as C3G, Sos1 and Dock180, and c-Abl and PI3K (p85
subunit), a protein and lipid kinase (reviewed in [42]). The
manipulation of Crk function by bacterial effectors is not
unprecedented. In Helicobactor pylori, CagA, a Type IV secretion
effector, is tyrosine-phosphorylated upon translocation and inter-
acts with Crk [55]. This interaction then triggers downstream
signaling events of Crk, including SoS1/H-Ras/Raf1, C3G/
Rap1/B-Raf and Dock180/ELMO pathway, resulting in CagA-
specific cell responses such as epithelial cell scattering and cell-cell
dissociation [55]. In Pseudomonas aeruginosa, exoenzyme T (ExoT)
ADP-ribosylates CrkI and CrkII thus preventing the binding of the
Crk SH2 domain to focal adhesion complex proteins, paxillin and
p130cas [56]. This leads to uncoupling of integrin signaling, actin
depolymerization, and potentially contributes to the anti-phago-
cytic activity of this opportunistic pathogen. The function of Crk in
C. trachomatis infection is less clear. Because the Crk-binding
partners Sos1 and Dock180 activate Rac1 [57,58] and Rac1
activation is partially required for C. trachomatis invasion [59], it is
possible that TepP, in addition to TARP [13], contributes to Rac1
activation at bacteria entry sites through its recruitment of Crk.
However, since TepP is not essential for bacterial entry or
establishment of the replicative vacuole within epithelial cells (Fig.
S6D), we see a limited role for this effector in the activation of
these pathways. Similarly, RNAi-mediated silencing of CrkI-II in
HeLa cells did not affect the ability of bacteria to enter and
replicate in these cells (Fig. S6A–C). These findings are in contrast
to observations made in Drosophila S2 cells where Crk was
identified as a potential host factor important for C. muridarum
growth [60], and suggest possible differences in cell lines or
Chlamydia strains used. At this stage we do not know the full
compendium of proteins recruited to nascent inclusions via TepP
and Crk-mediated protein scaffolding. However, it is clear from
the number of proteins that are tyrosine-phosphorylated in a
TepP-dependent manner that TepP contributes to multiple
signaling events during Chlamydia invasion.
Since signaling events often lead to changes in gene transcrip-
tion, we performed microarray analysis to compare the global
transcriptional response of A2EN cells to infection with the tepP
Figure 8. Model of the regulation and function of early effectors in signaling events occurring during the establishment of a
nascent Chlamydia inclusion. The EB form of C. trachomatis is pre-loaded with multiple T3S effectors and chaperones. The majority of TARP and
Ct694, two known early effectors, are pre-complexed with their cognate chaperone, Slc1, whereas only a small portion of TepP is in complex with
Slc1. Upon Chlamydia attachment, TARP and Ct694 are translocated into host cell cytoplasm, freeing Slc1 to associate with TepP and enhance its
secretion. TepP is translocated across membranes and phosphorylated by host tyrosine kinases. Phospho-TepP then recruits the host scaffolding
protein, Crk, through interacting with the SH2 domain of Crk. The SH3 domain of Crk then recruits other host proteins to the nascent inclusion to
initiate signaling cascades within the infected cell. TepP may also recruit additional proteins to initiate signaling responses independent of Crk.
doi:10.1371/journal.ppat.1003954.g008
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mutant versus its complemented counterpart. Interestingly, many
immune-related genes showed a TepP-dependent activation.
Among them, the most striking changes were observed for IFIT1
and IFIT2 with a fold-change more than 10 fold by 8 hpi (Fig. 7C).
IFIT1 and IFIT2 belong to a family of interferon-induced protein
with tetratricopeptide repeats (IFITs) that have a well-established
role in host anti-viral defense. IFIT proteins repress the translation
of viral genes by binding to eIF3, a translation initiation factor,
and virus RNA bearing 59-triphosphate, leading to suppression of
virus replication [61–63]. In addition, ectopic overexpression of
IFIT2 promotes cell death by a mitochondrial pathway, revealing
another potential anti-viral mechanism for these proteins [64].
The role of IFIT proteins in bacterial infections is less clear. In
murine macrophages, overexpression of IFIT2 represses lipopoly-
saccharide (LPS) induced TNF- a and IL-6 expression [65]. In
contrast, IFIT22/2 mice display reduced TNF- a and IL-6 in
serum and LPS-mediated lethality in an endotoxic shock model,
suggesting IFIT2 is a critical mediator for the secretion of LPS-
induced proinflammatory cytokines [66]. In C. trachomatis, both
IFIT1 and IFIT2 genes were reported to be up-regulated more
than 10 fold in HeLa 229 cells by 16 hpi [67]. Our study shows
that in the absence of TepP, the transcriptional level of IFIT1 and
IFIT2 is similar to the level of uninfected A2EN cells, implying
that TepP-mediated signaling regulates the expression of these
genes during C. trachomatis infection. IFIT1 and IFIT2 can be
induced directly by type I interferons [68], or indirectly after
activation of host pattern recognition receptors [69]. We are
currently investigating what TepP-mediated signal transduction
pathways may mediate the expression of IFITs and other genes
early in infection and the consequences of these transcriptional
events in colonization of the host.
Taken together, our data suggests that TepP acts as a
scaffolding protein that upon tyrosine phosphorylation, recruits
additional scaffolding proteins like Crk, which in turn recruit more
proteins to nascent inclusions, presumably to help establish an
early niche for replication within the host (Fig. 8). In addition, the
transcriptional response of host cells to infection with tepP mutants
suggest that there is a distinct gene expression program that is
dependent on TepP-mediated signaling events. We hypothesize
that the compendium of genes activated and repressed in a TepP-
dependent manner are important in establishing an immune
environment within infected tissues that is more conducive to C.
trachomatis colonization, survival and/or dissemination.
Materials and Methods
Cell lines, bacterial strains and reagents
Chlamydia trachomatis biovar LGV, serotype L2, strain 434/Bu
was propagated in HeLa cells or Vero cells maintained in
Dulbecco’s Modified Eagle Medium (Sigma-Aldrich, St. Louis,
Missouri, USA) supplemented with 10% fetal bovine serum (FBS)
(Mediatech, Manassas, Virginia, USA). Human endocervical
epithelial A2EN cells [45] were maintained in keratinocyte-SFM
medium (Gibco, Life Technologies corp., Grand Island, NY, USA)
supplemented with 10% FBS, 0.5 ng/mL human recombinant
epidermal growth factor and 50 mg/mL bovine pituitary extract.
EBs were purified by density gradient centrifugation using
Omnipaque 350 (GE Healthcare, Princeton, New Jersey, USA)
as previously described [31]. All recombinant protein expression
was performed in Escherichia coli strain BL21(DE3). The Y. pestis
KIM8-E (Dail) strain [70] used in this study is avirulent and is
excluded from the National Select Agent Registry due to the lack
of the 102-kb pgm locus [71]. In addition, this strain carries
deletions of the yopE, sycE and ail genes and has been cured of the
plasminogen activator (Pla)-encoding pPCP1 plasmid. All exper-
iments with Y. pestis KIM8-E (Dail) were reviewed and approved
by the Institutional Biosafety Committee at the University of
Miami. All reagents used are of analytical grade.
Generation of antibodies
Antibody generation was performed as previously described
[30]. Briefly, recombinant proteins: His-tagged Slc1 (Ct043) and
Mcsc (Ct260), and GST-tagged TepP (Ct875) were purified on
affinity resins and used to immunize New Zealand White rabbits.
Anti-GST antibodies were removed by pre-incubation with
recombinant GST, and anti-TepP antibodies were affinity purified
with TepP recombinant protein.
Identification of proteins that interact with T3S
chaperones
Immunoprecipitation (IP). Antibodies against Slc1 and
Mcsc were crosslinked separately to protein A/G resins (Pierce,
Rockford, Illinois, USA) using 40 mM Dimethyl pimelimidate
(Sigma-Aldrich, St. Louis, Missouri, USA) and the reactions were
quenched with 40 mM ethanolamine (Sigma-Aldrich, St. Louis,
Missouri, USA). Pre-immune serum was also crosslinked to resins
and served as a negative control. Approximately 361010 EBs were
lyzed by sonication in 1 mL Pierce IP lysis buffer (25 mM Tris,
150 mM NaCl, 1 mM EDTA, 1% NP-40, 5% glycerol;
pH 7.4)(Pierce, Rockford, Illinois, USA) supplemented with
1 mM phenylmethylsulphonyl fluoride (PMSF) and 1X EDTA-
free protease inhibitor cocktail (Roche, Basel, Switzerland). After
centrifugation to pellet down insoluble debris, the lysate was
incubated with the antibody-crosslinked resins at 4uC for 4 hours.
After 3 washes with IP lysis buffer, the bound proteins were eluted
with Pierce Elution buffer (pH 2.8) (Pierce, Rockford, Illinois,
USA) and separated via SDS-PAGE on a 4–12% Bis/Tris
gradient gel (Invitrogen Life Technologies, Carlsbad, California,
USA). Lanes were sliced into 8–10 equivalent sections for in-gel
digestion and analyzed by mass spectrometry at the Duke
Proteomics Core facility.
Liquid chromatography electrospray ionization tandem
mass spectrometry (LC-MS/MS). The in-gel digested pep-
tides from each band were analyzed via LC-MS/MS as follows:
ApproximatelyK of each digest (5 mL) was first trapped for 5 min
on a 5 mm Symmetry C18 180 mm I.D. 620 mm column at
20 mL/min in 99.9% mobile phase A, then an analytical
separation was performed using a 75 mm6250 mm BEH C18
column (Waters Corp., Milford, Maryland, USA) with a gradient
of 5 to 40% mobile phase B over 30 minutes, with a flow rate of
0.4 mL/min at 55uC column temperature, using a nanoAcquity
liquid chromatograph (Waters Corp., Milford, Maryland, USA).
The mobile phase consisted of (A) 0.1% formic acid in water and
(B) 0.1% formic acid in acetonitrile. Electrospray ionization was
used to introduce the sample in real-time to a Synapt G2 Q-Tof
mass spectrometer (Waters Corp., Milford, Maryland, USA),
collecting data for each sample in data-dependent analysis mode
with 0.6 second survey scans and three 0.6-second MS/MS scans
in CID mode of the top three most abundant multiply-charged
precursor ions. Raw data was processed in Mascot Distiller (v2.3)
and searched in Mascot v2.2 (Matrix Science) against a
concatenated database containing the deduplicated entries from
NCBInr with Chlamydia trachomatis taxonomy (http://www.ncbi.
nlm.nih.gov/pubmed/). For QToF data, search tolerances in
Mascot were 10 ppm on precursor and 0.04 Da on product ions,
requiring full trypsin specificity and allowing at most 2 missed
cleavages. Carbamidomethylation (+57.0214 Da, Cys) was includ-
ed as a fixed modification, and deamidation (Asn and Gln) and
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oxidation ((+15.9949 Da, Met) were allowed as variable modifi-
cations. Scaffold (v3.6.2, Proteome Software Inc.) was used to
validate MS/MS based peptide and protein identifications.
Peptide identifications were accepted if they could be established
at greater than 80% probability as specified by the Peptide
Prophet algorithm, and protein identifications were accepted if
they could be established at greater than 90% Protein Prophet
probability and contained at least 2 identified peptides [72,73].
The overall peptide and protein false discovery rate is 0%. Results
were from three independent biological replicates.
Co-purification of Slc1 with GST-tagged effectors and gel
filtration (size exclusion chromatography)
E. coli BL21(DE3) was co-transformed with a pET24d vector
expressing Slc1 and pGEX vector alone or pGEX expressing
individual GST-tagged test protein. Protein expression was
induced using 0.5 mM isopropyl-1-thio-b-d-galactopyranoside
(IPTG) for 3 hours at 37uC. Cells were pelleted and lysed by
sonication in binding buffer (1% Triton X-100, 20 mM Tris,
150 mM NaCl, 1 mM EDTA, 1 mM PMSF, pH 7.4), and GST–
tagged proteins were isolated from the supernatant using
glutathione-Sepharose beads (GE Healthcare, Pittsburgh, PA,
USA). After 4 h incubation, beads were washed 3 times with
binding buffer, followed by 3 washes with washing buffer (binding
buffer-0.2% Triton X-100, 300 mM NaCl). Bound proteins were
solubilized in 1X Laemmli sample buffer (20 mM Tris-HCl,
pH 6.8, 1% SDS, 5% Glycerol, 10 mM DTT, 0.01% bromophe-
nol blue) and resolved by SDS PAGE, followed by immunoblot
analysis with anti-Slc1 and –GST antibodies. Gel filtration
chromatography was performed on proteins expressed in E. coli
using a bi-cistronic vector to co-express untagged Slc1, with His-
tagged test proteins. The protein complexes were first purified
using a Nickel resin (GE Healthcare, Pittsburgh, PA, USA), eluted
with 500 mM imidazole and applied to a Superdex 200 gel
filtration column (GE Healthcare, Pittsburgh, PA, USA) for
analysis. Fractions from each sample were collected and analyzed
by immunoblot with anti-His and anti-Slc1 antibodies. Size
markers, alcohol dehydrogenase (150 kDa), Conalbumin (75 kDa)
and Carbonic Anhydrase (29 kDa) were purchased from GE and
Sigma.
Yersinia pestis T3S secretion assays
Yersinia pestis KIM8-E (Dail) was co-transformed with the
compatible plasmids pBAD33 and pBAD24 (Table S2) either
alone or in combination with pBAD plasmids encoding T3S
chaperones and putative effectors. Transformed bacteria were
grown overnight at 27uC in TMH media supplemented with
ampicillin and chloramphenicol. Overnight cultures were used to
inoculate fresh TMH media containing 2.5 mM calcium or
without calcium at OD620 = 0.2 and incubated for 1 hour at 27uC.
L-arabinose was added to 0.2% final concentration to induce
chaperone and effector proteins expression and the culture
temperature was shifted to 37uC for 5 hours. Bacteria were
harvested by centrifugation and cell pellets were separated from
culture supernatants. Proteins in the supernatant fractions were
precipitated with 10% (v/v) trichloroacetic acid, resuspended in
1X SDS-PAGE sample buffer and normalized to the final OD620
of the respective culture.
Indirect immunofluorescence staining
Approximately 56104 HeLa cells/well were seeded onto glass
coverslips placed in a 24 well plate. The following day, cells were
incubated with LGV-L2 EBs at an MOI of 20 and infections were
synchronized by centrifugation (3000 rpm for 30 min) at 10uC
followed by transferring the plates to a 37uC, 5% CO2 humidified
incubator. At the indicated time points, the coverslips were fixed
either with 100% methanol on ice for 15 min or with 3%
formaldehyde/0.025% glutaraldehyde at room temperature for
20 min. Cells were then permeabilized with 0.2% Triton in
phosphate buffer saline solution (PBS), blocked with 3% BSA in
PBS for 30 min and stained with antibodies against TepP (1:10),
LPS (1:250) (EV1-H1), MOMP (1:250) (gift from K. A. fields),
phosphotyrosine (1:100) (Cell signaling #9411), Slc1 (1:100), Crk
(1:10) (BD Transduction Laboratories 610035 clone 22). DAPI
(Invitrogen Life Technologies, Carlsbad, California, USA) was
used for staining nucleic acids. To permeabilize EBs at very early
time points, 0.005% SDS in PBS was used. The images were
further deconvolved using Huygens software (Scientific Volume
Imaging, Hilversum, Netherlands).
Protein lysates and IP of effector proteins
For short-term infections,,105 HeLa cells were seeded per well
in 24-well plates the day before experiment. Cells were incubated
with LGV-L2 or its mutant derivatives at a MOI of 100 and
infections were synchronized by centrifuging at 3000 rpm for
30 min at 10uC, followed by a shift to 37uC. Samples were
collected at indicated time points by washing the well once with
PBS followed by adding 90 mL 2X Laemmli sample buffer. For IPs
of effector proteins,,56106 HeLa cells were pre-seeded into a 10-
cm cell culture dish the day before infections and cells were
incubated with LGV-L2 or its mutant derivatives at a MOI of 100.
Infections were synchronized by pre-incubation for 1 hour at 4uC
in Hanks balanced salt solution, followed by the addition of
DMEM media pre-warmed to 37uC. At the indicated time points,
infected cells were washed two times with ice-cold PBS and lyzed
in 1 mL Pierce IP lysis buffer supplemented with 1 mM PMSF,
protease inhibitor cocktail and Halt phosphatase inhibitor (Pierce,
Rockford, Illinois, USA). After sonication and high speed
centrifugation to remove insoluble debris, antibodies against
TARP [74] or TepP were added to cell lysates and incubated
for 3 hours at 4uC. Protein A resin was added to isolate
immunocomplexes. After washing thoroughly with Pierce IP lysis
buffer, bound proteins were resolved by SDS PAGE and subjected
to immunoblot analysis.
Identification of TepP phosphorylation sites by LC-MS/
MS
IP. Two 15-cm cell culture dishes of confluent HeLa cells were
infected with LGVL-2 at a MOI of 100 as described above.
Another two dishes of confluent HeLa cells were mock-infected.
Four hours post treatment, cells were collected, washed twice with
PBS and lyzed as previously described [75] to generate cytosolic
and nuclear/EB fraction. After clarifying the cytosolic fraction by
high speed centrifugation, antibodies against TepP were added to
the infected and control cell lysates and incubated for 3 hours at
4uC with continuous mixing. Immunocomplexes were purified
with protein A resin and bound proteins were solubilized in SDS
sample buffer.
Phosphopeptide sample preparation and nano-flow LC-
MS/MS analysis. Following 1D-SDS-PAGE separation, the
molecular weight region corresponding to that of TepP was
excised and subjected to an in-gel trypsin digestion as previously
described [76]. Extracted peptides were brought to dryness using
vacuum centrifugation and resuspended in 100 mL 80% acetoni-
trile, 1% TFA, 50 mg/mL MassPrep Enhancer, pH 2.5 (Waters
Corp., Milford, Maryland, USA). Phosphopeptides were enriched
using a 200 mL TiO2 Protea Tip (Protea Bio., Morgantown, WV,
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USA) and subsequently washed with 200 mL 80% acetonitrile, 1%
TFA, 50 mg/mL MassPrep Enhancer followed by 200 mL 80%
acetonitrile, 1% TFA. Peptides were eluted in 50 mL 20%
acetonitrile, 5% aqueous ammonia, pH 10.5 and then acidified
to pH 2.5 with formic acid prior to drying using vacuum
centrifugation.
Samples were resuspended in 10 mL 2% acetonitrile, 0.1%
formic acid, 10 mM citric acid and subjected to chromatographic
separation on a Waters NanoAquity UPLC, in the same manner
as described for the immunoprecipitation samples, with the
following exceptions: the analytical column was held at 5% B
for 5 min at the beginning of the analytical separation, prior to a
linear elution gradient of 5% B to 40% B over 30 min. The
analytical column was connected to a fused silica PicoTip emitter
(New Objective, Cambridge, MA) with a 10 mm tip orifice and
coupled to an LTQ-Orbitrap XL mass spectrometer through an
electrospray interface. The instrument was set to acquire a
precursor MS scan in the Orbitrap from m/z 400–2000 with
r = 60,000 at m/z 400 and a target AGC setting of 1e6 ions. In a
data-dependent mode of acquisition, MS/MS spectra of the three
most abundant precursor ions were acquired in the linear ion trap
with a target AGC setting of 5e3 ions. Max fill times were set to
1000 ms for full MS scans and 250 ms for MS/MS scans with
minimum MS/MS triggering thresholds of 5000 counts. For all
experiments, fragmentation occurred in the LTQ linear ion trap
with a collision-induced dissociation (CID) energy setting of 35%
and a dynamic exclusion of 60 s was employed for previously
fragmented precursor ions.
Qualitative identifications and residue specific phos-
phorylation localization from raw LC-MS/MS data. Raw
data was processed in Mascot Distiller (v2.3) and searched in
Mascot v2.2 (Matrix Science) against a concatenated database
containing the deduplicated entries from NCBInr with Chlamydia
trachomatis taxonomy. Search tolerances for LTQ-Orbitrap XL
data were 10 ppm for precursor ions and 0.8 Da for product ions
using trypsin specificity with up to two missed cleavages.
Carbamidomethylation (+57.0214 Da, C) was set as a fixed
modification, whereas oxidation (+15.9949 Da, M) and phosphor-
ylation (+79.9663 Da, S, T, and Y) were considered a variable
modifications. All searched spectra were imported into Scaffold
and confidence thresholds were set using the PeptideProphet and
ProteinProphet algorithms which yielded a peptide and a protein
false discovery rate of 0% [72,73]. Phosphorylation site localiza-
tion was assessed by exporting peak lists directly from Scaffold into
the online AScore algorithm (ascore.med.harvard.ed) [77].
Identification and whole genome sequencing of a TepP-
deficient LGV-L2 strain
A strain containing a G309A (W103*) null allele in tepP was
initially identified by whole genome sequencing of a collection of
ethyl methyl sulfonate (EMS)-mutagenized and plaque-purified C.
trachomatis LGV-L2 strains generated as previously described [43]
(Bastidas R. J. and Valdivia R. H. unpublished results). Strain
CTL2-M062 harboring tepP G309A was identified from a pool of
20 mutants by Sanger sequencing of the tepP locus (CTL0255).
CTL2-MO62 was recovered in sucrose-phosphate-glutamate
(SPG) buffer (0.22 M sucrose, 0.01 M potassium phosphate,
0.005 M L-glutamic acid, pH 7.0) after hypotonic lysis of a
monolayer of infected HeLa cells grown in a 10-cm2 cell culture
dish. Lysates were sonicated (2610 seconds in ice water) and
bacterial cells were spun down at 14,000 rpm, for 15 minutes at
4uC, and resuspended in 1X DNAse I buffer (New England
Biolabs, Ipswich, MA, USA). Cell suspensions were treated with 4
Units of DNAse 1 (New England Biolabs, Ipswich, MA, USA) for
1 hour at 37uC to deplete contaminating host DNA. Following a
wash with PBS buffer, total DNA was isolated with a DNA
isolation kit (DNeasy tissue and blood kit, Qiagen, Valencia, CA,
USA) as described by the manufacturer.
For whole genome sequencing, 1 mg of CTL2-M062 enriched
DNA was fragmented with an Adaptive Focused Acoustics S220
instrument (Covaris, Inc. Woburn, MA, USA), and DNA
sequencing libraries were prepared with a library construction
kit (TruSeq DNA Sample Preparation Kit v2, Illumina, Inc. San
Diego, CA, USA) according to the manufacturer’s instructions.
Libraries were sequenced in a MiSeq DNA Sequencing Platform
(Illumina, Inc. San Diego, CA, USA) at the Duke University IGSP
DNA Sequencing Core facility. Genome assembly and single
nucleotide variant (SNV) identification was performed with
Geneious Software version 6 (Biomatters - http://www.geneious.
com/). The C. trachomatis L2 434/Bu genome (GenBank
no. NC_010287) was used as reference sequence. All non-
synonymous SNVs identified in CTL2-M062 (see Table S3) were
independently verified by Sanger sequencing.
Generation of Chlamydia recombinant strains
Chlamydia recombinants were generated as previously described
[43]. Briefly, confluent Vero cells grown on a 24-well plate were
co-infected with CTL2-MO62 (Rifampin resistant, RifR) and a
Spectinomycin resistant mapping strain (SpcR) at a ratio of 2:4 and
recombinant progenies were selected from among plaques that
formed in the presence of Rif (200 ng/mL) and Spc (200 mg/mL).
Plaque-purified recombinants were further expanded in Vero cells
and genotyped with SNV specific primers.
Chlamydia transformation
The gene encoding TepP and its predicted promoter region
(300 bp upstream of the TepP start codon) was amplified by PCR
from LGV-L2 genomic DNA and inserted into the E. coli-Chlamydia
shuttle vector p2TK2-SW2 [78]. The recombinant TepPW103* strains
(G1) were transformed with either empty vector or vector harboring
wild type TepP as previously described with some modifications [44].
Briefly, around 46106 Vero cells treated with transformation buffer
(10 mM Tris pH 7.4 in 50 mM CaCl2) were infected with G1 pre-
incubated with .6 mg plasmid in transformation buffer. Trans-
formed Chlamydia was selected under 1U of penicillin G (Sigma
P3032) for several passages. After initial selections, transformed
Chlamydia was maintained in the presence of 10U penicillin G. TepP
expression was confirmed by immunoblot analysis.
Microarray analysis
Approximately 0.86106 A2EN cells were seeded per well in 6-
well plates the day before experiment. Duplicate cell samples were
mock infected, or infected with the tepP mutant strain transformed
with empty vector or the vector harboring wild type tepP at an MOI
of 10. Infections were synchronized by centrifugation at 3000 rpm
for 30 min at 10uC, followed by an immediate shift to 37uC with
pre-warmed cell culture media. Samples were collected at 4 hpi
using QIAGEN RNeasy Plus Mini Kit (QIAGEN, Valencia, CA,
USA) as described by the manufacturer. RNA integrity was assessed
with Agilent 2100 Bioanalyzer G2939A (Agilent Technologies,
Santa Clara, CA, USA) and quantified with a Nanodrop 8000
spectrophotometer (Thermo Scientific/Nanodrop, Wilmington,
DE, USA). Hybridization targets were prepared with MessageAmp
Premier RNA Amplification Kit (Applied Biosystems/Ambion,
Austin, TX, USA) from total RNA, hybridized to GeneChip
Human Genome U133A 2.0 arrays in Affymetrix GeneChip
hybridization oven 645, washed in Affymetrix GeneChip Fluidics
Station 450 and scanned with Affymetrix GeneChip Scanner 7G
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according to standard Affymetrix GeneChip Hybridization, Wash,
and Stain protocols (Affymetrix, Santa Clara, CA, USA). Data
analysis was performed using Partek Genomic Suite 6.6 (Partek Inc.,
Saint Louis, MO, USA).
Quantitative real-time PCR (Q-PCR)
Q-PCR was performed using Power SYBR Green RNA-to-CT
1-Step Kit and StepOne Real-Time PCR system as described by
the manufacturer (Applied Biosystems, Grand Island, NY, USA).
Primers specific for IL-6, CXCL3, MAP3k8, IFIT1, IFIT2, and
Actin were designed using Roche Universal Probe Library (http://
www.roche-applied-science.com) and are listed in Table S5.
Primers against Chlamydia 16S rRNA were used to quantify the
amount of bacteria in each sample (Table S5).
Ethics statement
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11-12) was approved by the Duke University Office of Animal
Welfare Assurance (OAWA) after review by the IACUC
committee. The IACUC ensures compliance of this protocol with
the U.S Animal Welfare Act, Guide for Care and Use of
Laboratory Animals and Public Health Service Policy on Humane
Care and Use of Laboratory Animals.
Supporting Information
Figure S1 M/Z spectra of TepP phosphopeptides.
Endogenous TepP was immunoprecipitated at 4 hpi. The
corresponding TepP band was excised from the gel, digested with
trypsin and phosphopeptides were enriched on a titanium dioxide
affinity column, prior to elution and analysis by LC-MS/MS. Four
phospho-peptides were detected: two phosphoserine and two
phosphotyrosine. Detected peptides were shown above each
spectrum and detected phosphorylation site was underlined. Y-
axis is the relative intensity of peaks. X-axis is mass-to-charge ratio
(m/z).
(TIF)
Figure S2 Crk levels remain constant throughout infec-
tion. Confluent monolayer of HeLa cells were infected with wild
type LGV-L2 at anMOI of 50 and collected at indicated time points.
Samples were subjected to immunoblot analysis with antibodies
against Crk, Actin and MOMP. C: control uninfected cells.
(TIF)
Figure S3 Recombinant TepP interacts with GST-Crk in
a phosphorylation-dependent manner. Purified GST or
GST-Crk was incubated with purified TepP-6xHis or purified
TepP-6xHis that had been phosphorylated in vitro. One sample of
phosphorylated TepP-6xHis was treated with Calf intestinal
Alkaline Phosphatase (PPase). The efficiency of TepP co-
precipitation with GST-Crk increased after in vitro phosphoryla-
tion. Dephosphorylation with PPase decreased the efficiency of
GST-Crk co-precipitation.
(TIF)
Figure S4 C. trachomatis recombinant harboring a tepP
null allele (tepP W103*) does not express full length
TepP. EBs of four recombinants were selected from a co-infection
setting between CTL2-M062 (Rifr) and a Spcr LGV-L2 variant.
Recombinants were isolated by plaquing on Vero cell monolayers
in the presence of rifampin and spectinomycin. Individual plaques
were amplified on Vero cells, and EBs from recombinants with the
genotypes shown (also see Fig. S5) were harvested and purified on
density gradients. EBs were lyzed in SDS sample buffer, and
subjected to immunoblot analysis with antibodies against TEPP
and RpoB/B’, MOMP and Slc1.
(TIF)
Figure S5 Genotype of recombinant strains harboring
products of a CTL2-M062 (Rifr) and a LGV-L2 Spcr co-
infection. Black shading indicates single nucleotide variants
(SNV) present in CTL2-M062. Each SNV was verified by Sanger
sequencing.
(TIF)
Figure S6 Replication potential of LGV-L2 in Crk
knockdown cells and tepP mutants in epithelial cells.
A) Transfection of Crk siRNAs decreased the expression level of
both CrkI and CrkII in HeLa cells. Upper panel is the immunoblot
analysis of HeLa cells transfected with two different Crk siRNAs (3
and 5) or negative control siRNA (NC) for 48 h. Total cell lysates
were probed with anti-Crk and anti-Nup62 (loading control)
antibodies. B) Quantification of siRNA-mediated decreased levels
of Crk protein expression as assessed by quantitative immunoblots
on a LI-COR imager. CrkI and CrkII expression level was
decreased around 50% after siRNA treatment. C) Crk siRNA
knockdown does not affect C. trachomatis growth as assessed by IFU
assay. IFUs were normalized to growth in cells treated with control
siRNA (NC). D) Comparison of IFU burst between the tepP mutant
CTL2-MO62G1, and its derivatives transformed with empty vector
or pTepP. HeLa cells were infected for 28 h at an MOI,1. The
resulting infectious progeny were titered in HeLa cells as described
in Supplemental Material and Methods, and normalized to input
number of bacteria. All data shown were as means 6 standard
deviations from experiments performed in triplicate.
(TIF)
Table S1 Number of unique spectra identified by LC-
MS/MS from samples immunoprecipitated with anti-
Slc1 and anti-Mcsc antibodies from EBs.
(DOCX)
Table S2 Plasmid constructs used in this study.
(DOCX)
Table S3 Single nucleotide variants in strain CTL2-
M062.
(DOCX)
Table S4 List of genes that display a TepP-dependent
regulation at 4 hpi as determined bymicroarray analysis.
(DOCX)
Table S5 Primer sequences used for Q-PCR.
(DOCX)
Text S1 Supporting materials and methods.
(DOCX)
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